Pharmaceutical manufacturers are calling for reduced energy costs and enhanced active pharmaceutical ingredient (API) policies to strengthen medicine security, according to reporting from Independent Newspaper Nigeria. The industry stakeholders argue that these measures are necessary to ensure more reliable and sustainable production of medicines.